Federal contract award
HDTRA122C0013
ASSAY DEVELOPMENT AND IMPLEMENTATION TO IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | DEFENSE THREAT REDUCTION AGENCY |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AC33 — NATIONAL DEFENSE R&D SERVICES; DEFENSE-RELATED ACTIVITIES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $11.2M |
| Current contract value | $11.2M |
| Potential contract value / ceiling | $13.0M |
| Start date | Jun 23, 2022 |
| Current end date | Dec 23, 2026 |
| Potential end date | Jun 22, 2027 |
| Latest award activity | May 12, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 12 of 12 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 12, 2026 | P00011 | $0 | IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS |
| Dec 4, 2025 | P00010 | $1.3M | IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS |
| Jun 24, 2025 | P00009 | $0 | IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS |
| Jun 11, 2025 | P00008 | $711.5K | IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS |
| May 21, 2025 | P00007 | $0 | IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS |
| Jan 29, 2025 | P00006 | $1.5M | ASSAY DEVELOPMENT AND IMPLEMENTATION TO IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS |
| Jul 15, 2024 | P00005 | $0 | ASSAY DEVELOPMENT AND IMPLEMENTATION TO IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS. |
| Jun 12, 2024 | P00004 | $1.0M | ASSAY DEVELOPMENT AND IMPLEMENTATION TO IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS |
| Mar 6, 2024 | P00003 | $897.9K | ASSAY DEVELOPMENT AND IMPLEMENTATION TO IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS |
| Jun 20, 2023 | P00002 | $2.2M | ASSAY DEVELOPMENT AND IMPLEMENTATION TO IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS |
| Aug 30, 2022 | P00001 | $3.1M | ASSAY DEVELOPMENT AND IMPLEMENTATION TO IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS |
| Jun 22, 2022 | 0 | $510.8K | ASSAY DEVELOPMENT AND IMPLEMENTATION TO IDENTIFY VACCINE TARGETS AND EVALUATE COMPLEX VACCINES FOR BACTERIAL INFECTIONS |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-06-22 (240 days from calculation)
- +35 points
- 84 historical awards in this buyer and category group
- +15 points
- 12 recorded award transactions
- +10 points
- Latest award action: 2026-05-12
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.